A Bioequivalence Study of Capecitabine Tablets
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer or Metastatic Colorectal Cancer
Interventions: DRUG: Capecitabine tablets|DRUG: XELODA
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.